70
Participants
Start Date
December 13, 2021
Primary Completion Date
September 30, 2025
Study Completion Date
December 31, 2025
Pociredir oral capsule(s)
Participants will receive Pociredir
RECRUITING
Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg
RECRUITING
Jacobi Medical Center, The Bronx
RECRUITING
Queens Hospital Cancer Center, Jamaica
WITHDRAWN
Axon Clinical Research Institute, Baltimore
RECRUITING
Inova Schar Cancer Institute, Fairfax
RECRUITING
Virginia Commonwealth University, Richmond
RECRUITING
University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
Sonar Research Center, Atlanta
WITHDRAWN
Visionaries Clinical Research, Atlanta
WITHDRAWN
Atlanta Center for Medical Research, Atlanta
WITHDRAWN
Augusta University, Augusta
WITHDRAWN
Foundation for Sickle Cell Disease Research, LLC, Hollywood
WITHDRAWN
University of Miami Health System, Miami
WITHDRAWN
Mississippi Center for Advanced Medicine, Madison
RECRUITING
Our Lady of the Lake Hospital, Baton Rouge
RECRUITING
University of Arkansas for Medical Sciences (UAMS), Little Rock
RECRUITING
Lynn Health Science Institute, Oklahoma City
RECRUITING
University of Texas Houston, Houston
RECRUITING
University of California, Los Angeles, Los Angeles
RECRUITING
University of Ibadan, Ibadan
RECRUITING
Barau Dikko Teaching Hospital, Kaduna
RECRUITING
National Hospital, Abuja, Abuja
RECRUITING
Boston Medical Center, Boston
Lead Sponsor
Fulcrum Therapeutics
INDUSTRY